{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T15:53:38Z","timestamp":1768665218958,"version":"3.49.0"},"reference-count":126,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100005848","name":"Henry Luce Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005848","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011643","name":"Blavatnik Family Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011643","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009847","name":"Fordham University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009847","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100026294","name":"Barry Goldwater Scholarship and Excellence in Education Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100026294","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mol Model"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s00894-025-06586-3","type":"journal-article","created":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T05:27:36Z","timestamp":1767677256000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["An in silico approach to peptide-based dual-receptor targeting for IL13RA2 and VEGFR-2 extracellular domain"],"prefix":"10.1007","volume":"32","author":[{"given":"Saisha","family":"Islam","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liana R.","family":"Cutter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary A.","family":"Biggs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sophia A.","family":"Frantzeskos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6987-9717","authenticated-orcid":false,"given":"Ipsita A.","family":"Banerjee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,6]]},"reference":[{"issue":"2","key":"6586_CR1","doi-asserted-by":"publisher","first-page":"547","DOI":"10.3390\/v15020547","volume":"15","author":"A Hamad","year":"2023","unstructured":"Hamad A, Yusubalieva GM, Baklaushev VP, Chumakov PM, Lipatova AV (2023) Recent developments in glioblastoma therapy: oncolytic viruses and emerging future strategies. Viruses 15(2):547","journal-title":"Viruses"},{"issue":"5 Suppl","key":"6586_CR2","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.1188\/16.CJON.S1.2-8","volume":"20","author":"ME Davis","year":"2016","unstructured":"Davis ME (2016) Glioblastoma: overview of disease and treatment. Clin J Oncol Nurs 20(5 Suppl):S2\u2013S8","journal-title":"Clin J Oncol Nurs"},{"issue":"1","key":"6586_CR3","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22010351","volume":"22","author":"A Ou","year":"2020","unstructured":"Ou A, Yung WKA, Majd N (2020) Molecular mechanisms of treatment resistance in glioblastoma. Int J Mol Sci 22(1):351. https:\/\/doi.org\/10.3390\/ijms22010351","journal-title":"Int J Mol Sci"},{"key":"6586_CR4","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.coph.2019.01.006","volume":"47","author":"D Raucher","year":"2019","unstructured":"Raucher D (2019) Tumor targeting peptides: novel therapeutic strategies in glioblastoma. Curr Opin Pharmacol 47:14\u201319","journal-title":"Curr Opin Pharmacol"},{"issue":"8","key":"6586_CR5","doi-asserted-by":"publisher","first-page":"876","DOI":"10.3390\/biomedicines9080876","volume":"9","author":"DD Singh","year":"2021","unstructured":"Singh DD, Yadav DK (2021) TNBC: potential targeting of multiple receptors for a therapeutic breakthrough, nanomedicine, and immunotherapy. Biomedicines 9(8):876","journal-title":"Biomedicines"},{"issue":"11","key":"6586_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19113326","volume":"19","author":"P Sharma","year":"2018","unstructured":"Sharma P, Debinski W (2018) Receptor-targeted glial brain tumor therapies. Int J Mol Sci 19(11):3326. https:\/\/doi.org\/10.3390\/ijms19113326","journal-title":"Int J Mol Sci"},{"issue":"1","key":"6586_CR7","doi-asserted-by":"publisher","first-page":"512","DOI":"10.3892\/ol.2017.6221","volume":"14","author":"H Xu","year":"2017","unstructured":"Xu H, Zong H, Ma C, Ming X, Shang M, Li K, He X, Du H, Cao L (2017) Epidermal growth factor receptor in glioblastoma. Oncol Lett 14(1):512\u2013516","journal-title":"Oncol Lett"},{"key":"6586_CR8","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.cca.2014.05.004","volume":"436","author":"MJ Akhtar","year":"2014","unstructured":"Akhtar MJ, Ahamed M, Alhadlaq HA, Alrokayan SA, Kumar S (2014) Targeted anticancer therapy: overexpressed receptors and nanotechnology. Clin Chim Acta 436:78\u201392","journal-title":"Clin Chim Acta"},{"key":"6586_CR9","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.2147\/IJN.S238206","volume":"15","author":"L Peng","year":"2020","unstructured":"Peng L, Liang Y, Zhong X, Liang Z, Tian Y, Li S, Liang J, Wang R, Zhong Y, Shi Y, Zhang X (2020) Aptamer-conjugated gold nanoparticles targeting epidermal growth factor receptor variant III for the treatment of glioblastoma. Int J Nanomedicine 15:1363\u20131372","journal-title":"Int J Nanomedicine"},{"key":"6586_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2024.104115","volume":"29","author":"RTA Shivani","year":"2024","unstructured":"Shivani RTA, Chaudhary S (2024) Targeting cancer using scaffold-hopping approaches: illuminating SAR to improve drug design. Drug Discov Today 29:104115","journal-title":"Drug Discov Today"},{"issue":"1","key":"6586_CR11","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1186\/s12964-024-01607-9","volume":"22","author":"A Doostmohammadi","year":"2024","unstructured":"Doostmohammadi A, Jooya H, Ghorbanian K, Gohari S, Dadashpour M (2024) Potentials and future perspectives of multi-target drugs in cancer treatment: the next generation anti-cancer agents. Cell Commun Signal 22(1):228","journal-title":"Cell Commun Signal"},{"issue":"37","key":"6586_CR12","doi-asserted-by":"publisher","first-page":"59860","DOI":"10.18632\/oncotarget.10978","volume":"7","author":"S Ferluga","year":"2016","unstructured":"Ferluga S, Tom\u00e9 CM, Herpai DM, D\u2019Agostino R, Debinski W (2016) Simultaneous targeting of Eph receptors in glioblastoma. Oncotarget 7(37):59860\u201359876","journal-title":"Oncotarget"},{"issue":"1","key":"6586_CR13","volume":"2","author":"P Sharma","year":"2020","unstructured":"Sharma P, Sonawane P, Herpai D, D\u2019Agostino R, Rossmeisl J, Tatter S, Debinski W (2020) Multireceptor targeting of glioblastoma. Neurooncol Adv 2(1):vdaa107","journal-title":"Neurooncol Adv"},{"key":"6586_CR14","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.715000","volume":"12","author":"K Kim","year":"2021","unstructured":"Kim K, Gwak HS, Han N, Hong EK, Choi BK, Lee S, Choi S, Park JH, Seok JH, Jeon Y, Cho H, Lee SJ, Lee Y, Nam KT, Song SW (2021) Chimeric antigen receptor T cells with modified interleukin-13 preferentially recognize IL13R\u03b12 and suppress malignant glioma: a preclinical study. Front Immunol 12:715000","journal-title":"Front Immunol"},{"issue":"10","key":"6586_CR15","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.7150\/thno.12398","volume":"5","author":"L Geng","year":"2015","unstructured":"Geng L, Wang Z, Yang X, Li D, Lian W, Xiang Z, Wang W, Bu X, Lai W, Hu Z, Fang Q (2015) Structure-based design of peptides with high affinity and specificity to HER2 positive tumors. Theranostics 5(10):1154\u20131165","journal-title":"Theranostics"},{"issue":"6","key":"6586_CR16","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.3390\/biomedicines10061293","volume":"10","author":"SS Rinne","year":"2022","unstructured":"Rinne SS, Yin W, Borras AM, Abouzayed A, Leitao CD, Vorobyeva A, L\u00f6fblom J, St\u00e5hl S, Orlova A, Gr\u00e4slund T (2022) Targeting tumor cells overexpressing the human epidermal growth factor receptor 3 with potent drug conjugates based on affibody molecules. Biomedicines 10(6):1293","journal-title":"Biomedicines"},{"issue":"1","key":"6586_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/s41420-022-01198-9","volume":"8","author":"D Wang","year":"2022","unstructured":"Wang D, Liu J, Li T, Wang Y, Liu X, Bai Y, Wang C, Ju S, Huang S, Yang C, Zhou C, Zhang Y, Xiong B (2022) A VEGFR targeting peptide-drug conjugate (PDC) suppresses tumor angiogenesis in a TACE model for hepatocellular carcinoma therapy. Cell Death Discov 8(1):411","journal-title":"Cell Death Discov"},{"key":"6586_CR18","doi-asserted-by":"publisher","first-page":"1307860","DOI":"10.3389\/fphar.2023.1307860","volume":"14","author":"L Wang","year":"2024","unstructured":"Wang L, Liu WQ, Broussy S, Han B, Fang H (2024) Recent advances of anti-angiogenic inhibitors targeting VEGF\/VEGFR axis. Front Pharmacol 14:1307860","journal-title":"Front Pharmacol"},{"issue":"7","key":"6586_CR19","doi-asserted-by":"publisher","first-page":"13384","DOI":"10.3390\/molecules200713384","volume":"20","author":"LG Ferreira","year":"2015","unstructured":"Ferreira LG, Dos Santos RN, Oliva G, Andricopulo AD (2015) Molecular docking and structure-based drug design strategies. Molecules 20(7):13384\u201313421","journal-title":"Molecules"},{"key":"6586_CR20","doi-asserted-by":"publisher","DOI":"10.3390\/molecules27196203","volume":"27","author":"EB Elkaeed","year":"2022","unstructured":"Elkaeed EB, Yousef RG, Khalifa MM, Ibrahim A, Mehany AB, Gobaara IM, Alsfouk BA, Eldehna WM, Metwaly AM, Eissa IH, El-Zahabi MA (2022) Discovery of VEGFR-2 inhibitors: design, synthesis, antiproliferative evaluation, docking and MD simulation studies. Molecules 27:6203","journal-title":"Molecules"},{"issue":"1","key":"6586_CR21","doi-asserted-by":"publisher","DOI":"10.1007\/s00894-022-05427-x","volume":"29","author":"MR Parves","year":"2022","unstructured":"Parves MR, Riza YM, Alam S, Jaman S (2022) Molecular dynamics-based insight of VEGFR-2 kinase domain: a combined study of pharmacophore modeling and molecular docking and dynamics. J Mol Model 29(1):17. https:\/\/doi.org\/10.1007\/s00894-022-05427-x","journal-title":"J Mol Model"},{"key":"6586_CR22","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1002\/prot.22881","volume":"79","author":"S Madala","year":"2011","unstructured":"Madala S, Dolan MA, Sharma D, Ramalingam T, Wilson MS, Mentin-Kane MM, Masison DC, Wynn TA (2011) Mapping mouse IL-13 binding regions using structure modeling, molecular docking and high-density peptide microarray analysis. Proteins 79:282\u2013293","journal-title":"Proteins"},{"key":"6586_CR23","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.str.2010.01.003","volume":"18","author":"P Lupardus","year":"2010","unstructured":"Lupardus P, Birnbaum M, Garcia KC (2010) Molecular basis of shared cytokine recognition revealed in the structure of an unusually high affinity complex between IL-13 and IL-13R\u03b12. Structure 18:332\u2013342","journal-title":"Structure"},{"key":"6586_CR24","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2020.599281","volume":"8","author":"X Wang","year":"2020","unstructured":"Wang X, Bove AM, Simone G, Ma B (2020) Molecular basis of VEGFR2-mediated physiological function and pathological role. Front Cell Dev Biol 8:599281","journal-title":"Front Cell Dev Biol"},{"issue":"6","key":"6586_CR25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0130980","volume":"10","author":"N Shibasaki","year":"2015","unstructured":"Shibasaki N, Yamasaki T, Kanno T, Arakaki R, Sakamoto H, Utsunomiya N, Inoue T, Tsuruyama T, Nakamura E, Ogawa O, Kamba T (2015) Role of IL13RA2 in sunitinib resistance in clear cell renal cell carcinoma. PLoS One 10(6):e0130980","journal-title":"PLoS One"},{"issue":"1","key":"6586_CR26","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1158\/1078-0432.CCR-07-1990","volume":"14","author":"J Wykosky","year":"2008","unstructured":"Wykosky J, Gibo DM, Stanton C, Debinski W (2008) Interleukin-13 receptor alpha 2, EphA2, and Fos-related antigen 1 as molecular denominators of high-grade astrocytomas and specific targets for combinatorial therapy. Clin Cancer Res 14(1):199\u2013208","journal-title":"Clin Cancer Res"},{"issue":"10","key":"6586_CR27","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a009092","volume":"5","author":"M Shibuya","year":"2013","unstructured":"Shibuya M (2013) VEGFR and type-V RTK activation and signaling. Cold Spring Harb Perspect Biol 5(10):a009092","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"1","key":"6586_CR28","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.1080\/10717544.2022.2075986","volume":"29","author":"R Liang","year":"2022","unstructured":"Liang R, Wu C, Liu S, Zhao W (2022) Targeting interleukin-13 receptor \u03b12 (IL-13R\u03b12) for glioblastoma therapy with surface functionalized nanocarriers. Drug Deliv 29(1):1620\u20131630","journal-title":"Drug Deliv"},{"issue":"5","key":"6586_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2022.188802","volume":"1877","author":"M Ja\u00e9n","year":"2022","unstructured":"Ja\u00e9n M, Mart\u00edn-Regalado \u00c1, Bartolom\u00e9 RA, Robles J, Casal JI (2022) Interleukin 13 receptor alpha 2 (IL13R\u03b12): expression, signaling pathways and therapeutic applications in cancer. Biochimica et Biophysica Acta (BBA) 1877(5):188802. https:\/\/doi.org\/10.1016\/j.bbcan.2022.188802","journal-title":"Biochimica et Biophysica Acta (BBA)"},{"issue":"10","key":"6586_CR30","first-page":"720","volume":"29","author":"SP Weathers","year":"2015","unstructured":"Weathers SP, de Groot J (2015) VEGF manipulation in glioblastoma. Oncology (Williston Park) 29(10):720\u2013727","journal-title":"Oncology (Williston Park)"},{"key":"6586_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s42047-020-00060-5","volume":"3","author":"LV Loureiro","year":"2020","unstructured":"Loureiro LV, Neder L, Callegaro-Filho D, de Oliveira Koch L, Stavale JN, Malheiros SM (2020) The immunohistochemical landscape of the VEGF family and its receptors in glioblastomas. Surg Exp Pathol 3:1\u20138","journal-title":"Surg Exp Pathol"},{"key":"6586_CR32","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.13876","volume":"5","author":"S Sarabipour","year":"2016","unstructured":"Sarabipour S, Ballmer-Hofer K, Hristova K (2016) VEGFR-2 conformational switch in response to ligand binding. Elife 5:e13876","journal-title":"Elife"},{"issue":"31","key":"6586_CR33","doi-asserted-by":"publisher","first-page":"50997","DOI":"10.18632\/oncotarget.16549","volume":"8","author":"KKS Sai","year":"2017","unstructured":"Sai KKS, Sattiraju A, Almaguel FG, Xuan A, Rideout S, Krishnaswamy RS, Zhang J, Herpai DM, Debinski W, Mintz A (2017) Peptide-based PET imaging of the tumor restricted IL13RA2 biomarker. Oncotarget 8(31):50997\u201351007","journal-title":"Oncotarget"},{"issue":"26","key":"6586_CR34","doi-asserted-by":"publisher","first-page":"42997","DOI":"10.18632\/oncotarget.17792","volume":"8","author":"A Sattiraju","year":"2017","unstructured":"Sattiraju A, Solingapuram Sai KK, Xuan A, Pandya DN, Almaguel FG, Wadas TJ, Herpai DM, Debinski W, Mintz A (2017) IL13RA2 targeted alpha particle therapy against glioblastomas. Oncotarget 8(26):42997\u201343007","journal-title":"Oncotarget"},{"issue":"supplement 2","key":"6586_CR35","first-page":"1100","volume":"57","author":"KK Sai","year":"2016","unstructured":"Sai KK, Almaguel F, Sattiraju A, Herpai D, Debinski W, Mintz A (2016) Radiolabeling and initial biological evaluations of [64Cu] NOTA-Pep-1L for imaging glioblastoma (GBM). J Nucl Med 57(supplement 2):1100","journal-title":"J Nucl Med"},{"issue":"10","key":"6586_CR36","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15102772","volume":"15","author":"R Jannoo","year":"2023","unstructured":"Jannoo R, Walker W, Kanamarlapudi V (2023) Targeting and sensitization of breast cancer cells to killing with a novel interleukin-13 receptor \u03b1-2 specific hybrid cytolytic peptide. Cancers 15(10):2772","journal-title":"Cancers"},{"issue":"1","key":"6586_CR37","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1093\/neuonc\/nor141","volume":"14","author":"H Pandya","year":"2012","unstructured":"Pandya H, Gibo D, Garg S, Kridel S, Debinski W (2012) An interleukin 13 receptor \u03b12-specific peptide homes to human glioblastoma multiforme xenografts. Neuro Oncol 14(1):6\u201318. https:\/\/doi.org\/10.1093\/neuonc\/nor141","journal-title":"Neuro Oncol"},{"key":"6586_CR38","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s10822-013-9644-8","volume":"27","author":"GM Sastry","year":"2013","unstructured":"Sastry GM, Adzhigirey M, Day T, Annabhimoju R, Sherman W (2013) Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments. J Comput Aided Mol Des 27:221\u2013234","journal-title":"J Comput Aided Mol Des"},{"issue":"3","key":"6586_CR39","doi-asserted-by":"publisher","DOI":"10.1093\/bib\/bbaa153","volume":"22","author":"P Agrawal","year":"2021","unstructured":"Agrawal P, Bhagat D, Mahalwal M, Sharma N, Raghava GPS (2021) AntiCP 2.0: an updated model for predicting anticancer peptides. Brief Bioinform 22(3):bbaa153","journal-title":"Brief Bioinform"},{"key":"6586_CR40","doi-asserted-by":"publisher","first-page":"2812","DOI":"10.1093\/bioinformatics\/btr494","volume":"27","author":"C Mooney","year":"2011","unstructured":"Mooney C, Wang Y, Pollastri G (2011) SCLpred: protein subcellular localization prediction by N-to-1 neural networks. Bioinformatics 27:2812\u20132819","journal-title":"Bioinformatics"},{"key":"6586_CR41","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0045012","volume":"7","author":"C Mooney","year":"2012","unstructured":"Mooney C, Haslam N, Pollastri G, Shields DC (2012) Towards the improved discovery and design of functional peptides: common features of diverse classes permit general generalized prediction of bioactivity. PLoS One 7:e45012","journal-title":"PLoS One"},{"issue":"3","key":"6586_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.crmeth.2021.100014","volume":"1","author":"W Zheng","year":"2021","unstructured":"Zheng W, Zhang C, Li Y, Pearce R, Bell EW, Zhang Y (2021) Folding non-homologous proteins by coupling deep-learning contact maps with I-TASSER assembly simulations. Cell Rep Methods 1(3):100014","journal-title":"Cell Rep Methods"},{"key":"6586_CR43","doi-asserted-by":"publisher","first-page":"2619","DOI":"10.1038\/srep02619","volume":"3","author":"R Yan","year":"2013","unstructured":"Yan R, Xu D, Yang J, Walker S, Zhang Y (2013) A comparative assessment and analysis of 20 representative sequence alignment methods for protein structure prediction. Sci Rep 3:2619","journal-title":"Sci Rep"},{"issue":"W1","key":"6586_CR44","doi-asserted-by":"publisher","first-page":"W449","DOI":"10.1093\/nar\/gkw329","volume":"44","author":"A Lamiable","year":"2016","unstructured":"Lamiable A, Th\u00e9venet P, Rey J, Vavrusa M, Derreumaux P, Tuff\u00e9ry P (2016) PEP-FOLD3: faster de novo structure prediction for linear peptides in solution and in complex. Nucleic Acids Res 44(W1):W449\u2013W454","journal-title":"Nucleic Acids Res"},{"key":"6586_CR45","doi-asserted-by":"publisher","first-page":"4745","DOI":"10.1021\/ct500592m","volume":"10","author":"Y Shen","year":"2014","unstructured":"Shen Y, Maupetit J, Derreumaux P, Tuff\u00e9ry P (2014) Improved PEP-FOLD approach for peptide and miniprotein structure prediction. J Chem Theory Comput 10:4745\u20134758","journal-title":"J Chem Theory Comput"},{"key":"6586_CR46","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1002\/pro.3330","volume":"27","author":"CJ Williams","year":"2018","unstructured":"Williams CJ, Headd JJ, Moriarty NW, Prisant MG, Videau LL, Deis LN, Verma V, Keedy DA, Hintze BJ, Chen VB, Jain S, Lewis SM, Arendall WB 3rd, Snoeyink J, Adams PD, Lovell SC, Richardson JS, Richardson DC (2018) MolProbity: more and better reference data for improved all-atom structure validation. Protein Sci 27:293\u2013315","journal-title":"Protein Sci"},{"key":"6586_CR47","doi-asserted-by":"publisher","first-page":"W358","DOI":"10.1093\/nar\/gks577","volume":"40","author":"Y Gofman","year":"2012","unstructured":"Gofman Y, Haliloglu T, Ben-Tal N (2012) Monte Carlo simulations of peptide-membrane interactions with the MCPep web server. Nucleic Acids Res 40:W358\u2013W363","journal-title":"Nucleic Acids Res"},{"key":"6586_CR48","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/0095-8522(55)90027-1","volume":"10","author":"GH Bolt","year":"1955","unstructured":"Bolt GH (1955) Analysis of the validity of the Gouy-Chapman theory of the electric double layer. J Colloid Interface Sci 10:206\u2013218","journal-title":"J Colloid Interface Sci"},{"key":"6586_CR49","doi-asserted-by":"publisher","first-page":"3431","DOI":"10.1016\/S0006-3495(03)74765-1","volume":"85","author":"A Kessel","year":"2003","unstructured":"Kessel A, Shental-Bechor D, Haliloglu T, Ben-Tal N (2003) Interactions of hydrophobic peptides with lipid bilayers: Monte Carlo simulations with M2d. Biophys J 85:3431\u20133444","journal-title":"Biophys J"},{"issue":"7","key":"6586_CR50","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1182\/blood-2011-11-390922","volume":"119","author":"MS Brozzo","year":"2012","unstructured":"Brozzo MS, Bjeli\u0107 S, Kisko K, Schleier T, Lepp\u00e4nen VM, Alitalo K, Winkler FK, Ballmer-Hofer K (2012) Thermodynamic and structural description of allosterically regulated VEGFR-2 dimerization. Blood 119(7):1781\u20131788","journal-title":"Blood"},{"issue":"1","key":"6586_CR51","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1093\/nar\/28.1.235","volume":"28","author":"HM Berman","year":"2000","unstructured":"Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE (2000) The protein data bank. Nucleic Acids Res 28(1):235\u2013242","journal-title":"Nucleic Acids Res"},{"key":"6586_CR52","unstructured":"Schr\u00f6dinger L, DeLano W. PyMOL. (2020). Available from: http:\/\/www.pymol.org\/pymol"},{"key":"6586_CR53","doi-asserted-by":"crossref","unstructured":"Abramson J, Adler J, Dunger J, Evans R, Green T, Pritzel A, Ronneberger O, Willmore L, Ballard A, Banbrick J, Bodenstein s, Evans D, Hung C, O\u2019Neill M, Reiman D, Tunyasuvunakool K, Wu, \u017demgulyt\u0107 A, Avraniti E, Beattie C, Bertolli O, Bridgland A, Cherepanov, Congreve M, Cowen-Rivers, A.; Cowie A, Figurnov M, Fuchs F, Gladman H, Jain R, Khan Y, Low C, Perlin K, Potapenko A, Savy P, Singh S, Stecula A, Thillaisundaram A, Tong C, Yakeen S, Zhong E, Zielinksi M, Zidek A, Bapst V, Kohli P, Haderberg M, Hassabis D, Jumper J (2024) Accurate structure prediction of biomolecular interactions with AlphaFold 3. Nature, 630:493\u2013500.","DOI":"10.1038\/s41586-024-07487-w"},{"key":"6586_CR54","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1093\/bioinformatics\/btq066","volume":"25","author":"J Xu","year":"2010","unstructured":"Xu J, Zhang Y (2010) How significant is protein structure similarity with TM-score =0.5. Bioinformatics 25:889\u2013895","journal-title":"Bioinformatics"},{"key":"6586_CR55","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1093\/bioinformatics\/btp599","volume":"26","author":"J Yu","year":"2010","unstructured":"Yu J, Zhou Y, Tanaka I, Yao M (2010) Roll: a new algorithm for the detection of protein pockets and cavities with a rolling probe sphere. Bioinformatics 26:46\u201352","journal-title":"Bioinformatics"},{"key":"6586_CR56","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1002\/jcc.21334","volume":"31","author":"O Trott","year":"2010","unstructured":"Trott O, Olson AJ (2010) AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem 31:455\u2013461","journal-title":"J Comput Chem"},{"issue":"W1","key":"6586_CR57","doi-asserted-by":"publisher","first-page":"W443","DOI":"10.1093\/nar\/gky357","volume":"46","author":"P Zhou","year":"2018","unstructured":"Zhou P, Jin B, Li H, Huang SY (2018) HPEPDOCK: a webserver for blind peptide-protein docking based on a hierarchical algorithm. Nucleic Acids Res 46(W1):W443\u2013W450","journal-title":"Nucleic Acids Res"},{"key":"6586_CR58","doi-asserted-by":"publisher","first-page":"4109","DOI":"10.1093\/bioinformatics\/btac486","volume":"38","author":"H Tao","year":"2022","unstructured":"Tao H, Zhao X, Zhang K, Lin P, Huang SY (2022) Docking cyclic peptides formed by a disulfide bond through a hierarchical strategy. Bioinformatics 38:4109\u20134116","journal-title":"Bioinformatics"},{"key":"6586_CR59","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s13321-022-00605-8","volume":"14","author":"H Tao","year":"2022","unstructured":"Tao H, Wu Q, Zhao X, Lin P, Huang SY (2022) Efficient 3D conformer generation of cyclic peptides formed by a disulfide bond. J Cheminform 14:26","journal-title":"J Cheminform"},{"key":"6586_CR60","doi-asserted-by":"publisher","first-page":"2377","DOI":"10.1021\/acs.jcim.0c00058","volume":"60","author":"H Tao","year":"2020","unstructured":"Tao H, Zhang Y, Huang SY (2020) Improving protein-peptide docking results via pose-clustering and rescoring with a combined knowledge-based and MM-GBSA scoring function. J Chem Inf Model 60:2377\u20132387","journal-title":"J Chem Inf Model"},{"key":"6586_CR61","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1002\/prot.21949","volume":"72","author":"SY Huang","year":"2008","unstructured":"Huang SY, Zou X (2008) An iterative knowledge-based scoring function for protein-protein recognition. Proteins 72:557\u2013579","journal-title":"Proteins"},{"key":"6586_CR62","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1002\/prot.21214","volume":"66","author":"SY Huang","year":"2007","unstructured":"Huang SY, Zou X (2007) Ensemble docking of multiple protein structures: considering protein structural variations in molecular docking. Proteins 66:399\u2013421","journal-title":"Proteins"},{"key":"6586_CR63","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmb.2024.168548","volume":"436","author":"IA Guedes","year":"2024","unstructured":"Guedes IA, da Pereira Silva MM, Galheigo M, Krempser E, de Magalh\u00e3es CS, Correa Barbosa HJ, Dardenne LE (2024) DockThor-VS: a free platform for receptor-ligand virtual screening. J Mol Biol 436:168548","journal-title":"J Mol Biol"},{"issue":"1","key":"6586_CR64","doi-asserted-by":"publisher","first-page":"3198","DOI":"10.1038\/s41598-021-82410-1","volume":"11","author":"IA Guedes","year":"2021","unstructured":"Guedes IA, Barreto AMS, Marinho D, Krempser E, Kuenemann MA, Sperandio O, Dardenne LE, Miteva MA (2021) New machine learning and physics-based scoring functions for drug discovery. Sci Rep 11(1):3198","journal-title":"Sci Rep"},{"key":"6586_CR65","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1021\/acs.jcim.9b00905","volume":"60","author":"KB Santos","year":"2020","unstructured":"Santos KB, Guedes IA, Karl ALM, Dardenne LE (2020) Highly flexible ligand docking: benchmarking of the DockThor program on the LEADS-PEP protein-peptide data set. J Chem Inf Model 60:667\u2013683","journal-title":"J Chem Inf Model"},{"key":"6586_CR66","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.ins.2014.08.002","volume":"289","author":"CS De Magalh\u00e3es","year":"2014","unstructured":"De Magalh\u00e3es CS, Almeida DM, Barbosa HJ, Dardenne LE (2014) A dynamic niching genetic algorithm strategy for docking highly flexible ligands. Inf Sci 289:206\u2013224","journal-title":"Inf Sci"},{"issue":"W1","key":"6586_CR67","doi-asserted-by":"publisher","first-page":"W530","DOI":"10.1093\/nar\/gkab294","volume":"49","author":"MF Adasme","year":"2021","unstructured":"Adasme MF, Linnemann KL, Bolz SN, Kaiser F, Salentin S, Haupt VJ, Schroeder M (2021) PLIP 2021: expanding the scope of the protein-ligand interaction profiler to DNA and RNA. Nucleic Acids Res 49(W1):W530\u2013W534","journal-title":"Nucleic Acids Res"},{"key":"6586_CR68","doi-asserted-by":"publisher","first-page":"2778","DOI":"10.1021\/ci200227u","volume":"51","author":"RA Laskowski","year":"2011","unstructured":"Laskowski RA, Swindells MB (2011) Ligplot+: multiple ligand-protein interaction diagrams for drug discovery. J Chem Inf Model 51:2778\u20132786","journal-title":"J Chem Inf Model"},{"issue":"2","key":"6586_CR69","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1093\/protein\/8.2.127","volume":"8","author":"AC Wallace","year":"1995","unstructured":"Wallace AC, Laskowski RA, Thornton JM (1995) LIGPLOT: a program to generate schematic diagrams of protein-ligand interactions. Protein Eng 8(2):127\u2013134. https:\/\/doi.org\/10.1093\/protein\/8.2.127","journal-title":"Protein Eng"},{"key":"6586_CR70","doi-asserted-by":"crossref","unstructured":"Bowers KJ, Chow E, Xu H, Dror RO, Eastwood MP, Gregersen BA, Klepeis JL, Kolossvary I, Moraes MA, Sacerdoti FD, Salmon JK (2006) Scalable algorithms for molecular dynamics simulations on commodity clusters. Proceedings of the 2006 ACM\/IEEE Conference on Supercomputing., Tampa, FL, USA.","DOI":"10.1145\/1188455.1188544"},{"key":"6586_CR71","unstructured":"Desmond Molecular Dynamics System, D. E. Shaw Research, New York, NY (2023)."},{"key":"6586_CR72","unstructured":"Maestro-Desmond Interoperability Tools, Schr\u00f6dinger, New York, NY (2023)"},{"issue":"7","key":"6586_CR73","doi-asserted-by":"publisher","first-page":"4291","DOI":"10.1021\/acs.jctc.1c00302","volume":"17","author":"C Lu","year":"2021","unstructured":"Lu C, Wu C, Ghoreishi D, Chen W, Wang L, Damm W, Ross GA, Dahlgren MK, Russell E, Von Bargen CD, Abel R, Friesner RA, Harder ED (2021) OPLS4: improving force field accuracy on challenging regimes of chemical space. J Chem Theory Comput 17(7):4291\u20134300","journal-title":"J Chem Theory Comput"},{"key":"6586_CR74","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/978-1-62703-658-0_11","volume":"1084","author":"CC David","year":"2014","unstructured":"David CC, Jacobs DJ (2014) Principal component analysis: a method for determining the essential dynamics of proteins. Methods Mol Biol 1084:193\u2013226","journal-title":"Methods Mol Biol"},{"key":"6586_CR75","doi-asserted-by":"publisher","first-page":"3696","DOI":"10.1038\/s41598-024-54281-9","volume":"14","author":"S Yang","year":"2024","unstructured":"Yang S, Kar S (2024) Protracted molecular dynamics and secondary structure introspection to identify dual-target inhibitors of Nipah virus exerting approved small molecules repurposing. Sci Rep 14:3696","journal-title":"Sci Rep"},{"issue":"16","key":"6586_CR76","doi-asserted-by":"publisher","first-page":"9478","DOI":"10.1021\/acs.chemrev.9b00055","volume":"119","author":"E Wang","year":"2019","unstructured":"Wang E, Sun H, Wang J, Wang Z, Liu H, Zhang JZH, Hou T (2019) End-point binding free energy calculation with MM\/PBSA and MM\/GBSA: strategies and applications in drug design. Chem Rev 119(16):9478\u20139508","journal-title":"Chem Rev"},{"issue":"5","key":"6586_CR77","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1517\/17460441.2015.1032936","volume":"10","author":"S Genheden","year":"2015","unstructured":"Genheden S, Ryde U (2015) The MM\/PBSA and MM\/GBSA methods to estimate ligand-binding affinities. Expert Opin Drug Discov 10(5):449\u2013461","journal-title":"Expert Opin Drug Discov"},{"issue":"W1","key":"6586_CR78","doi-asserted-by":"publisher","first-page":"W5","DOI":"10.1093\/nar\/gkab255","volume":"49","author":"G Xiong","year":"2021","unstructured":"Xiong G, Wu Z, Yi J, Fu L, Yang Z, Hsieh C, Yin M, Zeng X, Wu C, Lu A, Chen X, Hou T, Cao D (2021) ADMETlab 2.0: an integrated online platform for accurate and comprehensive predictions of ADMET properties. Nucleic Acids Res 49(W1):W5\u2013W14","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"6586_CR79","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s13321-021-00557-5","volume":"13","author":"V Venkatraman","year":"2021","unstructured":"Venkatraman V (2021) FP-ADMET: a compendium of fingerprint-based ADMET prediction models. J Cheminform 13(1):75","journal-title":"J Cheminform"},{"key":"6586_CR80","doi-asserted-by":"crossref","unstructured":"Gasteiger E, Hoogland C, Gattiker A, Duvadud S, Wilkins MR, Appel R, Bairoch A. (2005) Protein identification and analysis tools on the ExPASy server. Chp. 52, pp. 571\u2013607, in John M. Walker (eds): The proteomics protocols handbook, Humana Press","DOI":"10.1385\/1-59259-890-0:571"},{"key":"6586_CR81","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpi.2023.100190","volume":"14","author":"F Sharifi","year":"2023","unstructured":"Sharifi F, Sharifi I, Babaei Z, Alahdin S, Afgar A (2023) Bioinformatics evaluation of anticancer properties of GP63 protein-derived peptides on MMP2 protein of melanoma cancer. J Pathol Inform 14:100190","journal-title":"J Pathol Inform"},{"key":"6586_CR82","doi-asserted-by":"publisher","DOI":"10.1186\/1472-6807-10-29","volume":"10","author":"N Bhattacharjee","year":"2010","unstructured":"Bhattacharjee N, Biswas P (2010) Position-specific propensities of amino acids in the \u03b2-strand. BMC Struct Biol 10:29","journal-title":"BMC Struct Biol"},{"key":"6586_CR83","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1038\/nprot.2010.5","volume":"5","author":"A Roy","year":"2010","unstructured":"Roy A, Kucukural A, Zhang Y (2010) I-tasser: a unified platform for automated protein structure and function prediction. Nat Protoc 5:725\u2013738","journal-title":"Nat Protoc"},{"key":"6586_CR84","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/j.jmb.2004.04.005","volume":"339","author":"A-C Camproux","year":"2004","unstructured":"Camproux A-C, Gautier R, Tuffery P (2004) A hidden markov model derived structural alphabet for proteins. J Mol Biol 339:591\u2013605","journal-title":"J Mol Biol"},{"key":"6586_CR85","doi-asserted-by":"publisher","DOI":"10.1186\/1472-6807-12-18","volume":"12","author":"K Fujiwara","year":"2012","unstructured":"Fujiwara K, Toda H, Ikeguchi M (2012) Dependence of \u03b1-helical and \u03b2-sheet amino acid propensities on the overall protein fold type. BMC Struct Biol 12:18","journal-title":"BMC Struct Biol"},{"key":"6586_CR86","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1016\/j.str.2020.08.005","volume":"28","author":"OV Sobolev","year":"2020","unstructured":"Sobolev OV, Afonine PV, Moriarty NW, Hekkelman ML, Joosten RP, Perrakis A, Adams PD (2020) A global ramachandran score identifies protein structures with unlikely stereochemistry. Structure (London, England) 28:1249\u20131258","journal-title":"Structure (London, England)"},{"key":"6586_CR87","doi-asserted-by":"publisher","first-page":"29145","DOI":"10.1038\/srep29145","volume":"6","author":"S Sun","year":"2016","unstructured":"Sun S, Zhao G, Huang Y, Cai M, Shan Y, Wang H, Chen Y (2016) Specificity and mechanism of action of alpha-helical membrane-active peptides interacting with model and biological membranes by single-molecule force spectroscopy. Sci Rep 6:29145","journal-title":"Sci Rep"},{"key":"6586_CR88","doi-asserted-by":"publisher","first-page":"2196","DOI":"10.1021\/acs.accounts.1c00047","volume":"54","author":"I Kabelka","year":"2021","unstructured":"Kabelka I, Vacha R (2021) Advances in molecular understanding of \u03b1-helical membrane active peptides. Acc Chem Res 54:2196\u20132204","journal-title":"Acc Chem Res"},{"key":"6586_CR89","doi-asserted-by":"publisher","first-page":"24915","DOI":"10.1074\/jbc.M502571200","volume":"280","author":"K Arima","year":"2005","unstructured":"Arima K, Sato K, Tanaka G, Kanaji S, Terada T, Honjo E, Kuroki R, Matsuo Y, Izuhara K (2005) Characterization of the interaction between interleukin-13 and interleukin-13 receptors. J Biol Chem 280:24915\u201324922","journal-title":"J Biol Chem"},{"key":"6586_CR90","doi-asserted-by":"publisher","first-page":"3891","DOI":"10.1021\/acs.jcim.1c00203","volume":"61","author":"J Eberhardt","year":"2021","unstructured":"Eberhardt J, Santos-Martins D, Tillack AF, Forli S (2021) AutoDock vina 1.2.0: new docking methods, expanded force field, and Python bindings. J Chem Inf Model 61:3891\u20133898","journal-title":"J Chem Inf Model"},{"key":"6586_CR91","doi-asserted-by":"publisher","DOI":"10.1017\/qrd.2022.14","volume":"3","author":"A Mondal","year":"2022","unstructured":"Mondal A, Chang L, Perez A (2022) Modeling peptide-protein complexes: docking simulations and machine learning. QRB Discov 3:d17","journal-title":"QRB Discov"},{"key":"6586_CR92","doi-asserted-by":"publisher","DOI":"10.1088\/1742-6596\/1228\/1\/012019","volume":"1228","author":"KN Naga Madhavilatha","year":"2019","unstructured":"Naga Madhavilatha KN, Mohan Babu GR (2019) Systematic approach for enrichment of docking outcome using consensus scoring functions. J Phys Conf Ser 1228:012919","journal-title":"J Phys Conf Ser"},{"key":"6586_CR93","doi-asserted-by":"publisher","DOI":"10.34172\/bi.2023.29955","volume":"14","author":"S Shamsian","year":"2023","unstructured":"Shamsian S, Sokouti B, Dastmalchi S (2023) Benchmarking different docking protocols for predicting the binding poses of ligands complexed with cyclooxygenase enzymes and screening libraries. Bioimpacts 14:29965","journal-title":"Bioimpacts"},{"issue":"4","key":"6586_CR94","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1016\/j.jaci.2013.08.006","volume":"133","author":"MJ Romeo","year":"2013","unstructured":"Romeo MJ, Agrawal R, Pomes A, Woodfolk J (2013) A molecular perspective of Th-2 promoting cytokine receptors in allergic disease. J Allergy Clin Immunol 133(4):952\u2013960","journal-title":"J Allergy Clin Immunol"},{"key":"6586_CR95","doi-asserted-by":"publisher","first-page":"193","DOI":"10.30699\/ijp.2024.2014231.3200","volume":"19","author":"Z Gholipour","year":"2024","unstructured":"Gholipour Z, Imani Fooladi AA, Parivar K (2024) Targeted therapy with a novel superantigen-based fusion protein against interleukin-13 receptor \u03b12-overexpressing tumor cells: an in-silico study. Iran J Pathol 19:193\u2013204","journal-title":"Iran J Pathol"},{"key":"6586_CR96","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2112006119","volume":"119","author":"LA Stern","year":"2022","unstructured":"Stern LA, Gholamin S, Moraga I, Yang X, Saravanakumar S, Cohen JR, Starr R, Aguilar B, Salvary V, Hibbard JC, Kalbasi A, Shepphird JK, O\u2019Hearn J, Garcia KC, Brown CE (2022) Engineered IL13 variants direct specificity of IL13R\u03b12-targeted CAR T cell therapy. Proc Natl Acad Sci USA 119:e2112006119","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8","key":"6586_CR97","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1038\/s41416-018-0259-7","volume":"119","author":"RA Bartolom\u00e9","year":"2018","unstructured":"Bartolom\u00e9 RA, Ja\u00e9n M, Casal JI (2018) An IL13R\u03b12 peptide exhibits therapeutic activity against metastatic colorectal cancer. Br J Cancer 119(8):940\u2013949","journal-title":"Br J Cancer"},{"key":"6586_CR98","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.ceb.2008.12.012","volume":"21","author":"M Lohela","year":"2009","unstructured":"Lohela M, Bry M, Tammela T, Alitalo K (2009) VEGFs and receptors involved angiogenesis versus lymphangiogenesis. Curr Opin Cell Biol 21:154\u2013165","journal-title":"Curr Opin Cell Biol"},{"key":"6586_CR99","doi-asserted-by":"publisher","first-page":"2425","DOI":"10.1073\/pnas.0914318107","volume":"107","author":"V-M Lepp\u00e4nen","year":"2010","unstructured":"Lepp\u00e4nen V-M, Prota A, Jeltsch M, Anisimov A, Kalkkinen N, Strandin T, Lankinen H, Goldman A, Ballmer-Hofer K (2010) Structural determinants of growth factor binding and specificity by VEGF receptor 2. PNAS 107:2425\u20132430","journal-title":"PNAS"},{"key":"6586_CR100","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.3390\/ijms19041264","volume":"19","author":"C Peach","year":"2018","unstructured":"Peach C, Mignone V, Arruda M, Alcobia D, Hill S, Kilpatrick L, Woolard J (2018) Molecular pharmacology of VEGF-A isoforms: binding and signaling at VEGFR2. Int J Mol Sci 19:1264","journal-title":"Int J Mol Sci"},{"key":"6586_CR101","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-63762-w","volume":"14","author":"Nayarisseri","year":"2024","unstructured":"Nayarisseri, Abdalla, Joshi, Yadav, Bhrdwaj, Chopra, Khan, Saxena, Sharma, Panicker, Panwar, Bezerra, Junior, Singh (2024) Potential inhibitors of VEGFR1, VEGFR2 and VEGFR3 developed through deep learning for the treatment of cervical cancer. Sci Rep 14:13251","journal-title":"Sci Rep"},{"key":"6586_CR102","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1182\/blood-2010-08-301549","volume":"117","author":"VM Lepp\u00e4nen","year":"2011","unstructured":"Lepp\u00e4nen VM, Jeltsch M, Anisimov A, Tvorogov D, Aho K, Kalkkinen N, Toivanen P, Yl\u00e4-Herttuala S, Ballmer-Hofer K, Alitalo K (2011) Structural determinants of vascular endothelial growth factor-D receptor binding and specificity. Blood 117:1507\u20131515","journal-title":"Blood"},{"key":"6586_CR103","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2020.599281","volume":"8","author":"X Wang","year":"2020","unstructured":"Wang X, Bove AM, Simone G, Ma B (2020) Molecular bases of VEGFR-2-mediated physiological function and pathological role. Front Cell Dev Biol 8:599281","journal-title":"Front Cell Dev Biol"},{"key":"6586_CR104","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1002\/prot.26280","volume":"90","author":"RS Depetris","year":"2022","unstructured":"Depetris RS, Lu D, Polonskaya Z, Zhang Z, Luna X, Tankard A, Kolahi P, Drummond M, Williams C, Ebert MCCJC, Patel JP, Poyurovsky MV (2022) Functional antibody characterization via direct structural analysis and information-driven protein-protein docking. Proteins 90:919\u2013935","journal-title":"Proteins"},{"key":"6586_CR105","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1038\/s41417-021-00379-5","volume":"29","author":"M Rusnati","year":"2022","unstructured":"Rusnati M, Paiardi G, Tobia C, Urbinati C, Lodola A, D\u2019Ursi P, Corrado M, Castelli R, Wade RC, Tognolini M, Chiodelli P (2022) Cholenic acid derivative UniPR1331 impairs tumor angiogenesis via blockade of VEGF\/VEGFR2 in addition to Eph\/ephrin. Cancer Gene Ther 29:908\u2013917","journal-title":"Cancer Gene Ther"},{"key":"6586_CR106","doi-asserted-by":"publisher","first-page":"14321","DOI":"10.1074\/jbc.275.19.14321","volume":"275","author":"D Lu","year":"2000","unstructured":"Lu D, Kussie P, Pytowski B, Persaud K, Bohlen P, Witte L, Zhu Z (2000) Identification of the residues in the extracellular region of KDR important for interaction with vascular endothelial growth factor and neutralizing anti-KDR antibodies. J Biol Chem 275:14321\u201314330","journal-title":"J Biol Chem"},{"key":"6586_CR107","first-page":"7007","volume":"7","author":"M G\u00f3ngora-Ben\u00edtez","year":"2014","unstructured":"G\u00f3ngora-Ben\u00edtez M, Tulla-Puche J, Albericio F (2014) Multifaceted roles of disulfide bonds. Peptides as therapeutics. Chemical reviews 114(2):901\u2013926 AND Kourra CMBK, Cramer N (2016) Converting disulfide bridges in native peptides to stable methylene thioacetals. Chem Sci 7:7007\u20137012","journal-title":"Chem Sci"},{"issue":"2","key":"6586_CR108","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/S1359-0278(98)00019-4","volume":"3","author":"BA Reva","year":"1998","unstructured":"Reva BA, Finkelstein AV, Skolnick J (1998) What is the probability of a chance prediction of a protein structure with an rmsd of 6 A? Fold Des 3(2):141\u2013147","journal-title":"Fold Des"},{"key":"6586_CR109","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/978-1-61779-588-6_10","volume":"857","author":"I Kufareva","year":"2012","unstructured":"Kufareva I, Abagyan R (2012) Methods of protein structure comparison. Methods Mol Biol 857:231\u2013257","journal-title":"Methods Mol Biol"},{"key":"6586_CR110","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1016\/j.neuron.2018.08.011","volume":"99","author":"SA Hollingsworth","year":"2018","unstructured":"Hollingsworth SA, Dror RO (2018) Molecular dynamics simulation for all. Neuron 99:1129\u20131143","journal-title":"Neuron"},{"key":"6586_CR111","doi-asserted-by":"publisher","first-page":"5538","DOI":"10.1038\/s41467-024-49858-x","volume":"15","author":"X Song","year":"2024","unstructured":"Song X, Bao L, Feng C, Huang Q, Zhang F, Gao X, Han R (2024) Accurate prediction of protein structural flexibility by deep learning integrating intricate atomic structures and cryo-EM density information. Nat Commun 15:5538","journal-title":"Nat Commun"},{"key":"6586_CR112","doi-asserted-by":"crossref","unstructured":"Galgale S, Zainab R, Kumar P, M Nithya, Susha D, Sharma Molecular docking and dynamic simulation based screening identifies inhibitors of targeted SARS-COV-2 eCLPRO and human ACE2. S Int J Appl Pharm 15(6):297\u2013308","DOI":"10.22159\/ijap.2023v15i6.48782"},{"key":"6586_CR113","doi-asserted-by":"publisher","DOI":"10.1016\/j.imu.2021.100514","volume":"23","author":"MB Boroujeni","year":"2021","unstructured":"Boroujeni MB, Dastjerdeh MS, Shokrgozar M, Rahimi H, Omidinia E (2021) Computational driven molecular dynamics simulation of keratinocyte growth factor behavior at different pH conditions. Inform Med Unlocked 23:100514","journal-title":"Inform Med Unlocked"},{"key":"6586_CR114","doi-asserted-by":"publisher","first-page":"1818","DOI":"10.3390\/pharmaceutics14091818","volume":"14","author":"JO Aribisala","year":"2022","unstructured":"Aribisala JO, Sabiu S (2022) Cheminformatics identification of phenolics as modulators of penicillin-binding protein 2a of Staphylococcus aureus: a structure-activity-relationship-based study. Pharmaceutics 14:1818","journal-title":"Pharmaceutics"},{"issue":"8","key":"6586_CR115","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0006476","volume":"4","author":"DN Ivankov","year":"2009","unstructured":"Ivankov DN, Bogatyreva NS, Lobanov MY, Galzitskaya OV (2009) Coupling between properties of the protein shape and the rate of protein folding. PLoS One 4(8):e6476","journal-title":"PLoS One"},{"key":"6586_CR116","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-50992-7","volume":"14","author":"V Pandya","year":"2024","unstructured":"Pandya V, Rao P, Prjapati J, Rawal R, Goswami D (2024) Pinpointing top inhibitors of GSK3\u03b2 from pool of indirubin derivatives using rigorous computational workflow and their validation using molecular dynamics (MD) simulations. Sci Rep 14:49","journal-title":"Sci Rep"},{"issue":"22","key":"6586_CR117","doi-asserted-by":"publisher","first-page":"14808","DOI":"10.1039\/D3RA01316B","volume":"13","author":"Y Jiang","year":"2023","unstructured":"Jiang Y, Yang W, Wang F, Zhou B (2023) In silico studies of a novel scaffold of benzoxazole derivatives as anticancer agents by 3D-QSAR, molecular docking and molecular dynamics simulations. RSC Adv 13(22):14808\u201314824","journal-title":"RSC Adv"},{"key":"6586_CR118","doi-asserted-by":"publisher","DOI":"10.1016\/j.chphi.2023.100401","volume":"8","author":"M Mandal","year":"2024","unstructured":"Mandal M, Mandal S (2024) MM-GBSA and QM\/MM simulation-based in silico approaches for the inhibition of Acinetobacter baumannii class D OXA-24 \u03b2-lactamase using antimicrobial peptides melittin and RP-1. Chem Phys Impact 8:1004012","journal-title":"Chem Phys Impact"},{"issue":"11","key":"6586_CR119","doi-asserted-by":"publisher","DOI":"10.3390\/md18110557","volume":"18","author":"AN Shikov","year":"2020","unstructured":"Shikov AN, Flisyuk EV, Obluchinskaya ED, Pozharitskaya ON (2020) Pharmacokinetics of marine-derived drugs. Mar Drugs 18(11):557. https:\/\/doi.org\/10.3390\/md18110557","journal-title":"Mar Drugs"},{"key":"6586_CR120","doi-asserted-by":"publisher","DOI":"10.3389\/fchem.2020.00726","volume":"8","author":"F Wu","year":"2020","unstructured":"Wu F, Zhou Y, Li L, Shen X, Chen G, Wang X, Liang X, Tan M, Huang Z (2020) Computational approaches in preclinical studies on drug discovery and development. Front Chem 8:726","journal-title":"Front Chem"},{"key":"6586_CR121","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.chroma.2012.07.078","volume":"1258","author":"D Lu","year":"2012","unstructured":"Lu D, Chambers P, Wipf P, Xie XQ, Englert D, Weber S (2012) Lipophilicity screening of novel drug-like compounds and comparison to clog P. J Chromatogr A 1258:161\u2013167","journal-title":"J Chromatogr A"},{"issue":"1","key":"6586_CR122","doi-asserted-by":"publisher","first-page":"59","DOI":"10.2165\/00003088-200342010-00003","volume":"42","author":"JH Lin","year":"2003","unstructured":"Lin JH, Yamazaki M (2003) Role of P-glycoprotein in pharmacokinetics: clinical implications. Clin Pharmacokinet 42(1):59\u201398. https:\/\/doi.org\/10.2165\/00003088-200342010-00003","journal-title":"Clin Pharmacokinet"},{"issue":"3","key":"6586_CR123","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1111\/j.1742-7843.2005.pto_973160.x","volume":"97","author":"MS Faber","year":"2005","unstructured":"Faber MS, Jetter A, Fuhr U (2005) Assessment of CYP1A2 activity in clinical practice: why, how and when? Basic Clin Pharmacol Toxicol 97(3):125\u2013134","journal-title":"Basic Clin Pharmacol Toxicol"},{"issue":"4","key":"6586_CR124","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1021\/mp300023x","volume":"9","author":"S Wang","year":"2012","unstructured":"Wang S, Li Y, Wang J, Chen L, Zhang L, Yu H, Hou T (2012) ADMET evaluation in drug discovery. 12. Development of binary classification models for prediction of hERG potassium channel blockage. Mol Pharm 9(4):996\u20131010","journal-title":"Mol Pharm"},{"key":"6586_CR125","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1074\/mcp.T400003-MCP200","volume":"3","author":"J Olsen","year":"2004","unstructured":"Olsen J, Ong S-E, Mann M (2004) Trypsin cleaves exclusively C-terminal to arginine and lysine residues. Mol Cell Proteomics 3:608\u2013614","journal-title":"Mol Cell Proteomics"},{"key":"6586_CR126","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1529\/biophysj.104.057158","volume":"89","author":"W Ma","year":"2005","unstructured":"Ma W, Tang C, Lai L (2005) Specificity of trypsin and chymotrypsin: loop-motion-controlled dynamic correlation as a determinant. Biophys J 89:1183\u20131193","journal-title":"Biophys J"}],"container-title":["Journal of Molecular Modeling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00894-025-06586-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00894-025-06586-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00894-025-06586-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T08:02:36Z","timestamp":1768636956000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00894-025-06586-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":126,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["6586"],"URL":"https:\/\/doi.org\/10.1007\/s00894-025-06586-3","relation":{},"ISSN":["1610-2940","0948-5023"],"issn-type":[{"value":"1610-2940","type":"print"},{"value":"0948-5023","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"5 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"NA.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"NA.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"All authors have given consent to publish.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"35"}}